AzTrials
AzTrials

Physical ActivityNCT03374436

Impact of Sprint Stair Climbing "Snacks" on Markers of Metabolism and Vascular Function

A study testing High-Carbohydrate Sedentary, High-Carbohydrate Active and Low-carbohydrate Sedentary in people with Physical Activity and Diet Modification, run by University of British Columbia at 1 site in Canada.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Prolonged sitting has been shown to impair metabolism and vascular function. The overall purpose of this study is to determine if breaking up prolonged (9 hours) of sitting with brief (~20 second) stair climbing exercise "snacks" can improve markers of metabolic control and vascular health in healthy young male… Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Physical Activity, Diet Modification
What is being tested?
High-Carbohydrate Sedentary, High-Carbohydrate Active and Low-carbohydrate Sedentary
Could I receive a placebo?
No, everyone receives an active treatment
How many people
23 participants
Where
1 siteCanada
Study dates
1 Oct 2017to 30 Aug 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Lean Group Inclusion Criteria:

Non-smoking

Lean Group Exclusion Criteria:

Diagnosed with diabetes or prediabetes (fasting blood sugar more than 6.0 mmol/l) or any other chronic condition that may impact glucose or insulin levels.

BMI is over 25 kg/m2 Take medications which may affect glucose and insulin levels Allergic to eggs. Smoker Competitive or serious endurance athlete.

Overweight/Obese Group Inclusion Criteria:

Elevated waist circumference (>102 cm for male and >88 cm for female)

Overweight/Obese Group Exclusion Criteria:

Diagnosed with diabetes (fasting blood sugar more than 7.0 mmol/l) Take medications which may affect glucose and insulin levels Allergic to eggs. Smoker Competitive or serious endurance athlete.

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • University of British Columbia Okanagan

    Kelowna, British Columbia, V1V 3G1

Other trials in Canada

About this study

Official title: Salivary Insulin Profiles Throughout the Day in Healthy Humans

Prolonged sitting has been shown to impair metabolism and vascular function. The overall purpose of this study is to determine if breaking up prolonged (9 hours) of sitting with brief (~20 second) stair climbing exercise "snacks" can improve markers of metabolic control and vascular health in healthy young male participants and in males or females with overweight/obesity who are at risk of insulin resistance. An additional purpose is to determine if saliva insulin can be used as a valid indicator of blood insulin when measured throughout the day in sedentary and active conditions and when diets with different amounts of carbohydrates are consumed.

Being tested
High-Carbohydrate Sedentary, High-Carbohydrate Active, Low-carbohydrate Sedentary
Medical subject headings
Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • High-Carbohydrate SedentaryBehavioural

    Three high-carbohydrate meals will be consumed (breakfast, lunch, and dinner) at ~3 hour intervals while participants remain in a seated position for the entire 9 hour intervention period.

  • High-Carbohydrate ActiveBehavioural

    Three high-carbohydrate meals will be consumed (breakfast, lunch, and dinner) at ~3 hour intervals while participants remain in a seated position for the entire 9 hour intervention period except that once every hour they will ascend three flights of stairs vigorously (stair climbing sprint "snack") for a total of 8 active breaks.

  • Low-carbohydrate SedentaryBehavioural

    Three low-carbohydrate meals will be consumed (breakfast, lunch, and dinner) at ~3 hour intervals while participants remain in a seated position for the entire 9 hour intervention period. This condition will provide a condition where the blood glucose and insulin responses are relatively low and stable throughout the day.

Study groups in NCT03374436
Study groupRoleWhat they receive
High-Carbohydrate SedentaryExperimentalParticipants will remain seated for 9 hours (except for using the restroom) while consuming a high-carbohydrate diet (3 meals)
Receives: Behavioral: High-Carbohydrate Sedentary
High-Carbohydrate ActiveExperimentalParticipants will remain seated for 9 hours (except for using the restroom) while consuming a high-carbohydrate diet (3 meals) but will complete 8 stair climbing sprint "snacks" once per hour involving ascending 3 flights of stairs at a vigorous pace (~20 seconds each).
Receives: Behavioral: High-Carbohydrate Active
Low-Carbohydrate SedentaryActive comparatorParticipants will remain seated for 9 hours (except for using the restroom) while consuming a low-carbohydrate diet (3 meals)
Receives: Behavioral: Low-carbohydrate Sedentary

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Plasma insulin area under the curve

    The plasma insulin concentration measured by enzyme-linked immunosorbent assay area under the curve will be measured using the trapezoidal rule.

    Measured: Measured across 9 hours of each intervention day

Secondary outcomes (7)
  1. Saliva insulin area under the curve

    The saliva insulin concentration measured by enzyme-linked immunosorbent assay area under the curve will be measured using the trapezoidal rule.

    Measured: Measured across 9 hours of each intervention day

  2. Plasma glucose area under the curve

    The plasma glucose concentration measured by hexokinase method area under the curve will be measured using the trapezoidal rule.

    Measured: Measured across 9 hours of each intervention day

  3. Plasma triglyceride area under the curve

    The plasma triglyceride concentration measured by biochemical assay area under the curve will be measured using the trapezoidal rule.

    Measured: Measured across 9 hours of each intervention day

  4. Plasma non-esterified fatty acids area under the curve

    The plasma non-esterified fatty acid concentration measured by biochemical assay area under the curve will be measured using the trapezoidal rule.

    Measured: Measured across 9 hours of each intervention day

  5. Femoral artery flow-mediated dilation

    Flow-mediated dilation of femoral artery measured by vascular ultrasound

    Measured: Measured in the morning (time 0 hours) and afternoon (time 8.5 hours) each intervention day

  6. Cerebrovascular function

    Cerebrovascular function measured by transcranial doppler ultrasound

    Measured: Measured in the morning (time 0.5 hours) and afternoon (time 6 hours) each intervention day

  7. Cognitive function

    Cognitive function measured by Computerized Neurocognitive Assessment Software (CNS) Vital Signs test battery

    Measured: Measured in the morning (time 0.5 hours) and afternoon (time 6 hours) each intervention day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Dec 2017
  2. Study start1 Oct 2017
  3. Primary completion30 Jun 2019
  4. Study completion30 Aug 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Crossover
Model description
Participants complete three conditions in a repeated crossover design.
Masking
None (open label)
Enrolment
23 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03374436
Sponsor's protocol ID
H17-01747
Status last verified
Sep 2019
First submitted
11 Dec 2017
Last updated
25 Sep 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: We will share individual patient data (de-identified) with researchers upon request.

Publications

  • Rafiei H, Omidian K, Chang CR, Little JP. Saliva insulin tracks plasma insulin across the day following high-carbohydrate and low-carbohydrate meals. Appl Physiol Nutr Metab. 2023 Sep 1;48(9):700-709. doi: 10.1139/apnm-2023-0066. Epub 2023 Jun 1.

    PubMed 37262929
  • Caldwell HG, Coombs GB, Rafiei H, Ainslie PN, Little JP. Hourly staircase sprinting exercise "snacks" improve femoral artery shear patterns but not flow-mediated dilation or cerebrovascular regulation: a pilot study. Appl Physiol Nutr Metab. 2021 May;46(5):521-529. doi: 10.1139/apnm-2020-0562. Epub 2020 Nov 26.

    PubMed 33242251

Questions about this trial

What is this clinical trial studying?

A study testing High-Carbohydrate Sedentary, High-Carbohydrate Active and Low-carbohydrate Sedentary in people with Physical Activity and Diet Modification, run by University of British Columbia at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Sep 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Plasma insulin area under the curve (time frame: Measured across 9 hours of each intervention day). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03374436, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Sep 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in